# GoodRx (GDRX) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/GDRX
## Company Profile
- Ticker: GDRX
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 3.59 USD
- Market cap: 999092350.35 USD
- Last updated: 2026-08-12
## Business Overview
### Medication-Savings Platform
GoodRx is a U.S. digital platform that helps consumers compare prescription prices and access discounts at pharmacies.
### Consumer and Provider Network
The service connects consumers, pharmacies, pharmacy-benefit managers, manufacturers and healthcare professionals. Users access savings through the website, mobile applications and provider workflows.
### Revenue Model
GoodRx earns transaction-based prescription revenue, subscription fees and manufacturer-solutions revenue from affordability, awareness and patient-support programs.
## Why The Stock Is Moving

As of Aug 12, 2026, GDRX closed down 5.53% at $3.59. No new same-company headline was identified in the current news window.

## Recent News
- 2026-08-05 20:05 EST — [GoodRx Reports Second Quarter 2026 Results](https://biopharmsignal.com/news/GDRX/goodrx-reports-second-quarter-2026-results-7441e3c7) — Source: GoodRx
- 2026-07-09 20:05 EST — [GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/GDRX/goodrx-announces-date-for-second-quarter-2026-earnings-release-and-conference-ca-172941f0) — Source: GoodRx
- 2026-05-27 13:00 EST — [GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs](https://biopharmsignal.com/news/GDRX/goodrx-launches-goodrx-companion-a-new-subscription-designed-to-lower-everyday-healthcare-costs) — Source: GoodRx
- 2026-05-06 20:05 EST — [GoodRx Reports First Quarter 2026 Results](https://biopharmsignal.com/news/GDRX/goodrx-reports-first-quarter-2026-results) — Source: GoodRx
- 2026-05-01 12:10 EST — [GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients](https://biopharmsignal.com/news/GDRX/goodrx-expands-offerings-to-now-include-ozempicr-pill-for-type-2-diabetes-patients) — Source: GoodRx